{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:55:36Z","timestamp":1783472136304,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T00:00:00Z","timestamp":1502064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T00:00:00Z","timestamp":1502064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2015-0753"],"award-info":[{"award-number":["2015-0753"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s10637-017-0497-1","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T00:38:51Z","timestamp":1502066331000},"page":"163-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing"],"prefix":"10.1007","volume":"36","author":[{"given":"Kyoungmin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhoon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-pyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heung-Moon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Lyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woochang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Jun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Wan","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Koo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hyun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Wook","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Byung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baek-Yeol","family":"Ryoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,7]]},"reference":[{"issue":"1","key":"497_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9\u201329","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"497_CR2","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1200\/JCO.2014.59.7930","volume":"33","author":"GM Heestand","year":"2015","unstructured":"Heestand GM, Murphy JD, Lowy AM (2015) Approach to patients with pancreatic cancer without detectable metastases. J Clin Oncol 33(16):1770\u20131778","journal-title":"J Clin Oncol"},{"issue":"12","key":"497_CR3","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa032295","volume":"350","author":"JP Neoptolemos","year":"2004","unstructured":"Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350(12):1200\u20131210","journal-title":"N Engl J Med"},{"issue":"10","key":"497_CR4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/jama.2010.1275","volume":"304","author":"JP Neoptolemos","year":"2010","unstructured":"Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D et al (2010) Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 304(10):1073\u20131081","journal-title":"JAMA"},{"issue":"14","key":"497_CR5","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/jama.2013.279201","volume":"310","author":"H Oettle","year":"2013","unstructured":"Oettle H, Neuhaus P, Hochhaus A, Hartmann JT, Gellert K, Ridwelski K et al (2013) Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA 310(14):1473\u20131481","journal-title":"JAMA"},{"issue":"19","key":"497_CR6","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364(19):1817\u20131825","journal-title":"N Engl J Med"},{"issue":"9","key":"497_CR7","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/cncr.27927","volume":"119","author":"R Shridhar","year":"2013","unstructured":"Shridhar R, Almhanna K, Hoffe SE, Fulp W, Weber J, Chuong MD et al (2013) Increased survival associated with surgery and radiation therapy in metastatic gastric cancer: a surveillance, epidemiology, and end results database analysis. Cancer 119(9):1636\u20131642","journal-title":"Cancer"},{"issue":"3","key":"497_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0025-7125(05)70249-2","volume":"84","author":"RE Brand","year":"2000","unstructured":"Brand RE, Lynch HT (2000) Hereditary pancreatic adenocarcinoma. A clinical perspective. Med Clin North Am 84(3):665\u2013675","journal-title":"Med Clin North Am"},{"issue":"28","key":"497_CR9","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1200\/JCO.2015.61.6961","volume":"33","author":"J Carnevale","year":"2015","unstructured":"Carnevale J, Ashworth A (2015) Assessing the significance of BRCA1 and BRCA2 mutations in pancreatic cancer. J Clin Oncol 33(28):3080\u20133081","journal-title":"J Clin Oncol"},{"issue":"15","key":"497_CR10","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"Breast Cancer Linkage C","year":"1999","unstructured":"Breast Cancer Linkage C (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91(15):1310\u20131316","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"497_CR11","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","volume":"94","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton DF (2002) Breast cancer linkage C. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94(18):1358\u20131365","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"497_CR12","first-page":"1059","volume":"60","author":"E Levy-Lahad","year":"1997","unstructured":"Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E et al (1997) Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet 60(5):1059\u20131067","journal-title":"Am J Hum Genet"},{"issue":"5","key":"497_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/GIM.0b013e3181d38f2f","volume":"12","author":"N Petrucelli","year":"2010","unstructured":"Petrucelli N, Daly MB, Feldman GL (2010) Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. Genet Med 12(5):245\u2013259","journal-title":"Genet Med"},{"issue":"34","key":"497_CR14","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1200\/JCO.2016.67.0554","volume":"34","author":"KN Maxwell","year":"2016","unstructured":"Maxwell KN, Domchek SM, Nathanson KL, Robson ME (2016) Population frequency of germline BRCA1\/2 mutations. J Clin Oncol 34(34):4183\u20134185","journal-title":"J Clin Oncol"},{"issue":"3","key":"497_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1200\/JCO.2014.56.2728","volume":"33","author":"B Kaufman","year":"2015","unstructured":"Kaufman B, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balmana J et al (2015) Olaparib monotherapy in patients with advanced cancer and a germline BRCA1\/2 mutation. J Clin Oncol 33(3):244\u2013250","journal-title":"J Clin Oncol"},{"issue":"7540","key":"497_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P et al (2015) Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518(7540):495\u2013501","journal-title":"Nature"},{"issue":"6","key":"497_CR17","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/bjc.2014.418","volume":"111","author":"T Golan","year":"2014","unstructured":"Golan T, Kanji ZS, Epelbaum R, Devaud N, Dagan E, Holter S et al (2014) Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers. Br J Cancer 111(6):1132\u20131138","journal-title":"Br J Cancer"},{"issue":"13","key":"497_CR18","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1002\/cncr.28662","volume":"120","author":"AL Lucas","year":"2014","unstructured":"Lucas AL, Frado LE, Hwang C, Kumar S, Khanna LG, Levinson EJ et al (2014) BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts. Cancer 120(13):1960\u20131967","journal-title":"Cancer"},{"issue":"3","key":"497_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jnci\/95.3.214","volume":"95","author":"SA Hahn","year":"2003","unstructured":"Hahn SA, Greenhalf B, Ellis I, Sina-Frey M, Rieder H, Korte B et al (2003) BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 95(3):214\u2013221","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"497_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1158\/1055-9965.EPI-06-0783","volume":"16","author":"FJ Couch","year":"2007","unstructured":"Couch FJ, Johnson MR, Rabe KG, Brune K, de Andrade M, Goggins M et al (2007) The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol Biomark Prev 16(2):342\u2013346","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"497_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11032-015-0329-y","volume":"35","author":"M Caro","year":"2015","unstructured":"Caro M, Verlaan MG, Julian O, Finkers R, Wolters AM, Hutton SF et al (2015) Assessing the genetic variation of ty-1 and ty-3 alleles conferring resistance to tomato yellow leaf curl virus in a broad tomato germplasm. Mol Breed 35(6):132","journal-title":"Mol Breed"},{"issue":"28","key":"497_CR22","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1200\/JCO.2014.59.7401","volume":"33","author":"S Holter","year":"2015","unstructured":"Holter S, Borgida A, Dodd A, Grant R, Semotiuk K, Hedley D et al (2015) Germline BRCA mutations in a large clinic-based cohort of patients with pancreatic adenocarcinoma. J Clin Oncol 33(28):3124\u20133129","journal-title":"J Clin Oncol"},{"issue":"4","key":"497_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/MPA.0b013e31815c75ea","volume":"36","author":"JH Cho","year":"2008","unstructured":"Cho JH, Bang S, Park SW, Chung JB, Song SY (2008) BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group. Pancreas 36(4):337\u2013340","journal-title":"Pancreas"},{"issue":"2","key":"497_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.6004\/jnccn.2016.0018","volume":"14","author":"MB Daly","year":"2016","unstructured":"Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B et al (2016) Genetic\/familial high-risk assessment: breast and ovarian, version 2.2015. J Natl Compr Cancer Netw 14(2):153\u2013162","journal-title":"J Natl Compr Cancer Netw"},{"key":"497_CR25","doi-asserted-by":"crossref","unstructured":"Gloria M. Petersen KGC, Robert R. McWilliams, Neil Majithia, Brian Allen, John Kidd, Nanda Singh, Anne-Renee Hartman, Ann L. Oberg (2016). Mayo Clinic, Rochester, MN; Myriad Genetics, Inc., Salt Lake City, UT. Genetic heterogeneity and survival among pancreatic adenocarcinoma (PDAC) patients with positive family history. In: 2016 ASCO Annual Meeting: J Clin Oncol","DOI":"10.1200\/JCO.2016.34.15_suppl.4108"},{"key":"497_CR26","doi-asserted-by":"crossref","unstructured":"Golan T, Sela T, Margalit O, Amit U, Halpern N, Aderka D, et al. Short and long-term survival in metastatic pancreatic adenocarcinoma, 1993\u20132013. J Clin Oncol 2017;35(4_suppl):232\u2013232","DOI":"10.1200\/JCO.2017.35.4_suppl.232"},{"issue":"24","key":"497_CR27","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1002\/cncr.29664","volume":"121","author":"EE Salo-Mullen","year":"2015","unstructured":"Salo-Mullen EE, O'Reilly EM, Kelsen DP, Ashraf AM, Lowery MA, Yu KH et al (2015) Identification of germline genetic mutations in patients with pancreatic cancer. Cancer 121(24):4382\u20134388","journal-title":"Cancer"},{"issue":"45","key":"497_CR28","doi-asserted-by":"publisher","first-page":"74227","DOI":"10.18632\/oncotarget.12490","volume":"7","author":"E Takai","year":"2016","unstructured":"Takai E, Yachida S, Shimizu K, Furuse J, Kubo E, Ohmoto A et al (2016) Germline mutations in Japanese familial pancreatic cancer patients. Oncotarget 7(45):74227\u201374235","journal-title":"Oncotarget"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-017-0497-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-017-0497-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-017-0497-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T05:12:59Z","timestamp":1678511579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-017-0497-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["497"],"URL":"https:\/\/doi.org\/10.1007\/s10637-017-0497-1","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,7]]},"assertion":[{"value":"4 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was supported by a grant (2015\u20130753) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors indicate no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study was approved by the Institutional Review Board of the Asan Medical Center and informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}